BACKGROUND: Several factors have been identified as predictors of events after transcatheter aortic valve implantation (TAVI) but the impact of left ventricular ejection fraction (LVEF) and mean transaortic gradient (MTG) is controversial. This multicenter study aimed to clarify the prognostic role of low LVEF and low MTG after TAVI. METHODS: From 2007 to 2012, 764 consecutive patients with severe symptomatic aortic valve stenosis underwent TAVI at participating hospitals. Patients were divided according to LVEF and MTG into four groups. RESULTS: Sixty-four patients had LVEF 40% or less and MTG less than 40 mmHg, 76 had LVEF 40% or less and MTG at least 40 mmHg, 163 had LVEF more than 40% and MTG less than 40 mmHg, 461 had LVEF more than 40% and MTG at least 40 mmHg. Two-year mortality was significantly higher in patients with low LVEF and low MTG, whereas it was similar in patients with low LVEF and high MTG, high LVEF and low MTG, and high LVEF and high MTG (51.3 vs. 22.4 vs. 23.3. vs. 25.5%, respectively; P = 0.001). These results were confirmed by multivariate analysis, as the combination of low LVEF and low MTG (both less than 40) was identified as the stronger mid-term mortality predictor (hazard ratio 2.4, confidence interval 95% 1.4-3.9; P = 0.001). CONCLUSION: At least one parameter between LVEF or MTG over 40 predicts a good prognosis for TAVI patients at mid-term follow-up, whereas those with both left ventricular dysfunction and low mean aortic pressure gradient are at high risk of all-cause death after TAVI.

Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: The rule of 40

D'Ascenzo, Fabrizio;Salizzoni, Stefano;RINALDI, Mauro;GAITA, Fiorenzo
2017-01-01

Abstract

BACKGROUND: Several factors have been identified as predictors of events after transcatheter aortic valve implantation (TAVI) but the impact of left ventricular ejection fraction (LVEF) and mean transaortic gradient (MTG) is controversial. This multicenter study aimed to clarify the prognostic role of low LVEF and low MTG after TAVI. METHODS: From 2007 to 2012, 764 consecutive patients with severe symptomatic aortic valve stenosis underwent TAVI at participating hospitals. Patients were divided according to LVEF and MTG into four groups. RESULTS: Sixty-four patients had LVEF 40% or less and MTG less than 40 mmHg, 76 had LVEF 40% or less and MTG at least 40 mmHg, 163 had LVEF more than 40% and MTG less than 40 mmHg, 461 had LVEF more than 40% and MTG at least 40 mmHg. Two-year mortality was significantly higher in patients with low LVEF and low MTG, whereas it was similar in patients with low LVEF and high MTG, high LVEF and low MTG, and high LVEF and high MTG (51.3 vs. 22.4 vs. 23.3. vs. 25.5%, respectively; P = 0.001). These results were confirmed by multivariate analysis, as the combination of low LVEF and low MTG (both less than 40) was identified as the stronger mid-term mortality predictor (hazard ratio 2.4, confidence interval 95% 1.4-3.9; P = 0.001). CONCLUSION: At least one parameter between LVEF or MTG over 40 predicts a good prognosis for TAVI patients at mid-term follow-up, whereas those with both left ventricular dysfunction and low mean aortic pressure gradient are at high risk of all-cause death after TAVI.
2017
18
2
103
108
http://journals.lww.com/jcardiovascularmedicine
Heart failure; Mean transaortic gradient; Severe aortic stenosis; Transcatheter aortic valve implantation; Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Echocardiography; Female; Follow-Up Studies; Humans; Italy; Kaplan-Meier Estimate; Male; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Severity of Illness Index; Transcatheter Aortic Valve Replacement; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Stroke Volume; Cardiology and Cardiovascular Medicine
Conrotto, Federico; D'Ascenzo, Fabrizio; Stella, Pieter; Pavani, Marco; Rossi, Marco Luciano; Brambilla, Nedy; Napodano, Massimo; Covolo, Elisa; Saia, Francesco; Tarantini, Giuseppe; Agostoni, Pierfrancesco; Marzocchi, Antonio; Presbitero, Patrizia; Bedogni, Francesco; Salizzoni, Stefano; D'Amico, Maurizio; Moretti, Claudio; Rinaldi, Mauro; Gaita, Fiorenzo
File in questo prodotto:
File Dimensione Formato  
Transcatheter.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 247.38 kB
Formato Adobe PDF
247.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1646733
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact